COMMUNIQUÉS West-GlobeNewswire

Aptevo Therapeutics to Present New Preclinical Data for APVO436 and ALG.APV.527 at the American Association for Cancer Research 2019 Annual Meeting
25/03/2019
SEATTLE, March 25, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology, autoimmune and hematology therapeutics, today announced that preclinical [...]
BioStem Technologies, Inc. Announces Corporate Update
25/03/2019
Pompano Beach, FL, March 25, 2019 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), today provided a corporate update to the Company’s continuing growth strategy. In January [...]
Addressing the Opioid Epidemic Through a Shifted Focus
25/03/2019
Opioid Clinical Management leverages predictive analytics to help self-insured employers attack costs and over-prescribing by providers DES MOINES, Iowa, March 25, 2019 (GLOBE NEWSWIRE) -- As the nation copes with the [...]
Pain Therapeutics Reports 2018 Financial Results and Corporate Update
25/03/2019
2019 Focus Is on Alzheimer’s Disease, Rebranding the Company, Conducting Phase II Studies and Fiscal Discipline AUSTIN, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today reported [...]
Advantis Corp Signs Lease For Orange County Location
25/03/2019
NEWPORT BEACH, CA, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it has signed the lease for the new Orange County operating location. According to Advantis [...]
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Featured in CannabisNewsAudio Publication on Soaring Hemp Based CBD Industry
25/03/2019
NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) announces the availability of a CannabisNewsAudio Publication titled, “ CBD Industry Soars in Wake of [...]
Menlo Therapeutics Announces Publication of Serlopitant Phase 2 Data for the Treatment of Pruritus Associated with Prurigo Nodularis
25/03/2019
Data Published in the Journal of the American Academy of Dermatology REDWOOD CITY, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the [...]
ExCellThera announces clearance by FDA and Health Canada for ECT-001 in new clinical trials in United States and Canada for the treatment of leukemia
25/03/2019
MONTREAL, March 25, 2019 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced [...]
Nuvectra® Appoints Anthony P. Bihl, III as New Chairman of the Board
25/03/2019
Elects Jane J. Song to the Board of Directors PLANO, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Anthony P [...]
Allscripts FollowMyHealth helping drive digital transformation with patient/consumer engagement platform; Expands relationship with Ephraim McDowell Health
25/03/2019
CHICAGO, March 25, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) FollowMyHealth® today announced partnership with Ephraim McDowell Health on its enterprise and mobile patient engagement platform. “Innovative [...]
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Business Progress
25/03/2019
NDA filing for ET-202 Accepted for Review and Assigned PDUFA Date of October 21, 2019 DEER PARK, Ill., March 25, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company [...]
Ceapro Inc. Announces Issuance of Indian Patent Application for Enabling Pressurized Gas eXpanded (PGX) Technology
25/03/2019
Company continues to build solid IP portfolio for its unique and disruptive enabling PGX technology with protection now in the U.S., Canada, Europe and India EDMONTON, Alberta, March 25, 2019 (GLOBE NEWSWIRE) -- Ceapro [...]
Mersana Therapeutics Announces Poster and Presentation at the American Association for Cancer Research Annual Meeting 2019
25/03/2019
CAMBRIDGE, Mass., March 25, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Zogenix to Present at Two Investor Conferences in April
25/03/2019
EMERYVILLE, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that members of management will participate on [...]
Wave Life Sciences to Present Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design at the Muscular Dystrophy Association Clinical and Scientific Conference
25/03/2019
CAMBRIDGE, Mass., March 25, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating [...]
Rubius Therapeutics Appoints Natalie Holles to its Board of Directors and Greg Whitehead as Senior Vice President and Chief Quality Officer
25/03/2019
CAMBRIDGE, Mass., March 25, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
Tonix Pharmaceuticals to Present at Upcoming Investor Conferences
25/03/2019
NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Company management will present at two upcoming investor conferences. Details [...]
Soleno Therapeutics to Participate in the ROTH Battle of NASH Thrones Spring Investor Conference
25/03/2019
REDWOOD CITY, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
VBL Therapeutics to Present at Upcoming Conferences in April
25/03/2019
TEL AVIV, Israel, March 25, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), today announces that the Company will present data on its Phase 3 drug candidate VB-111, at the 2019 American Association for Cancer [...]

Pages